The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions
- PMID: 21466053
The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions
Abstract
Purpose: Our aim was to evaluate the efficacy of Proton-MR Spectroscopy for the differentiation of cranial masses from non-neoplastic brain disorders.
Material and method: 33 patients with intracranial mass lesions, 29 patients with non-neoplastic brain lesions: Ischemic-demyelinating-metabolic-benign cystic mass group; As a whole 62 patients: 30 males and 32 females were included in this study.
Results: In brain tumours, average Cho/NAA ratio 2.84-NAA/Cr ratio was 0.97, Cho/Cr ratio 2.42 and Cho/MI ratio was 3.51. In non-neoplastic group; NAA/Cr ratio was extremely higher than tumour group, the other ratios were far lower than cranial mass lesions. Average Cho/NAA ratio: 0.50 +/- 0.15, Cho/Cr ratio: 1.05 +/- 0.14, Cho/MI ratio: 1.07 +/- 0.73.
Conclusion: Higher Cho/NAA and Cho/MI ratios with lower NAA/Cr ratio were most likely to be malignant. Additional lipid and lactate peaks were generally seen in malignant group.
Similar articles
-
Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.Magn Reson Imaging. 2011 Jan;29(1):25-31. doi: 10.1016/j.mri.2010.07.017. Epub 2010 Sep 15. Magn Reson Imaging. 2011. PMID: 20832225
-
Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.Clin Imaging. 2010 Jan-Feb;34(1):47-52. doi: 10.1016/j.clinimag.2009.03.013. Clin Imaging. 2010. PMID: 20122519
-
1H MR spectroscopy in the assessment of gliomatosis cerebri.AJR Am J Roentgenol. 2007 Mar;188(3):710-4. doi: 10.2214/AJR.06.0055. AJR Am J Roentgenol. 2007. PMID: 17312058
-
1H MR spectroscopy of brain tumours and masses.NMR Biomed. 2003 May;16(3):123-31. doi: 10.1002/nbm.822. NMR Biomed. 2003. PMID: 12884355 Review.
-
MR spectroscopy of brain tumors.Magn Reson Imaging Clin N Am. 2003 Aug;11(3):415-29, v-vi. doi: 10.1016/s1064-9689(03)00061-8. Magn Reson Imaging Clin N Am. 2003. PMID: 14768727 Review.
Cited by
-
Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas.Cureus. 2022 Nov 23;14(11):e31841. doi: 10.7759/cureus.31841. eCollection 2022 Nov. Cureus. 2022. PMID: 36579207 Free PMC article.
-
Evaluation of Two Post-Processing Analysis Methods of Proton Magnetic Resonance Spectroscopy in Glioma Tumors.J Biomed Phys Eng. 2023 Feb 1;13(1):39-44. doi: 10.31661/jbpe.v0i0.2001-1055. eCollection 2023 Feb. J Biomed Phys Eng. 2023. PMID: 36818014 Free PMC article.
-
Overview of current multiparametric magnetic resonance imaging approach in the diagnosis and staging of prostate cancer.Kaohsiung J Med Sci. 2015 Apr;31(4):167-78. doi: 10.1016/j.kjms.2015.01.002. Epub 2015 Feb 17. Kaohsiung J Med Sci. 2015. PMID: 25835272 Free PMC article. Review.
-
Proton magnetic resonance spectroscopy of periventricular white matter and hippocampus in obstructive sleep apnea patients.Pol J Radiol. 2013 Oct;78(4):7-14. doi: 10.12659/PJR.889923. Epub 2013 Nov 19. Pol J Radiol. 2013. PMID: 24505219 Free PMC article.
-
Diagnostic Value of Diffusion-weighted Magnetic Resonance (MR) Imaging, MR Perfusion, and MR Spectroscopy in Addition to Conventional MR Imaging in Intracranial Space-occupying Lesions.Cureus. 2019 Dec 18;11(12):e6409. doi: 10.7759/cureus.6409. Cureus. 2019. PMID: 31970039 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials